Cargando...
Non-Genetically Improving the Natural Cytotoxicity of Natural Killer (NK) Cells
The innate lymphocyte lineage natural killer (NK) is now the target of multiple clinical applications, although none has received an agreement from any regulatory agency yet. Transplant of naïve NK cells has not proven efficient enough in the vast majority of clinical trials. Hence, new protocols wi...
Guardado en:
| Publicado en: | Front Immunol |
|---|---|
| Autores principales: | , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Frontiers Media S.A.
2020
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6970430/ https://ncbi.nlm.nih.gov/pubmed/31998309 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2019.03026 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|